Injectable sodium pentobarbital: Stability at room temperature
Sodium pentobarbital (Nembutal) is a barbiturate used in research as an anesthetic in many animal models. The injectable form of this drug has lately become difficult to procure and prohibitively expensive. Due to this lack of availability, researchers have begun to compound injectable sodium pentob...
Gespeichert in:
Veröffentlicht in: | Journal of pharmacological and toxicological methods 2015-11, Vol.76, p.38-42 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 42 |
---|---|
container_issue | |
container_start_page | 38 |
container_title | Journal of pharmacological and toxicological methods |
container_volume | 76 |
creator | Priest, Sydney M. Geisbuhler, Timothy P. |
description | Sodium pentobarbital (Nembutal) is a barbiturate used in research as an anesthetic in many animal models. The injectable form of this drug has lately become difficult to procure and prohibitively expensive. Due to this lack of availability, researchers have begun to compound injectable sodium pentobarbital from so-called “nonpharmaceutical” pentobarbital. Some oversight agencies have objected to this practice, claiming a lack of quality control and degradation of the drug. We sought with this study to establish both: 1) a protocol for the preparation of injectable sodium pentobarbital, and 2) standard operating procedures to monitor the quality of the preparation and degradation of the drug over time.
Our preparation consists of a mixture of sodium pentobarbital in alkaline aqueous solution, propylene glycol, and ethanol. Pentobarbital content in this preparation was assayed by high-pressure liquid chromatography (HPLC). We also assayed pentobarbital content over time in preparations of various ages up to 6years old.
We determined that the drug degraded at a maximum of 0.5% per year in our preparation (alkaline water/propylene glycol/ethanol) when stored in the dark at room temperature. A yellow discoloration developed after about 2years, which we have arbitrarily determined disqualifies the preparation from use as an anesthetic. Attempts to spectroscopically assay this discoloration were not successful.
Pentobarbital sodium (CID: 14075609) |
doi_str_mv | 10.1016/j.vascn.2015.07.012 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1732597771</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1056871915000945</els_id><sourcerecordid>1732597771</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-97a591022b984a103cd41804fa6aa19332dc0189c52b85581d18c8e51615c5f03</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMofv8CQXr00ppJmiYRFGTxCwQPKngLaToLWfqxJunC_nuru3r0NAPzvDPMQ8gZ0AIoVJeLYmWj6wtGQRRUFhTYDjkEJXleKvWxO_VUVLmSoA_IUYwLSinXUO6TA1YxXpayPCQ3T_0CXbJ1i1kcGj922RL7NNQ21D7Z9ip7nYa-9Wmd2ZSFYeiyhN0Sg01jwBOyN7dtxNNtPSbv93dvs8f8-eXhaXb7nDsudMq1tEIDZazWqrRAuWtKULSc28pa0JyzxlFQ2glWKyEUNKCcQgEVCCfmlB-Ti83eZRg-R4zJdD46bFvb4zBGA5IzoaWUMKF8g7owxBhwbpbBdzasDVDzLc4szI848y3OUGkmcVPqfHtgrDts_jK_pibgegPg9ObKYzDReewdNj5MAk0z-H8PfAGMqn7X</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1732597771</pqid></control><display><type>article</type><title>Injectable sodium pentobarbital: Stability at room temperature</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Priest, Sydney M. ; Geisbuhler, Timothy P.</creator><creatorcontrib>Priest, Sydney M. ; Geisbuhler, Timothy P.</creatorcontrib><description>Sodium pentobarbital (Nembutal) is a barbiturate used in research as an anesthetic in many animal models. The injectable form of this drug has lately become difficult to procure and prohibitively expensive. Due to this lack of availability, researchers have begun to compound injectable sodium pentobarbital from so-called “nonpharmaceutical” pentobarbital. Some oversight agencies have objected to this practice, claiming a lack of quality control and degradation of the drug. We sought with this study to establish both: 1) a protocol for the preparation of injectable sodium pentobarbital, and 2) standard operating procedures to monitor the quality of the preparation and degradation of the drug over time.
Our preparation consists of a mixture of sodium pentobarbital in alkaline aqueous solution, propylene glycol, and ethanol. Pentobarbital content in this preparation was assayed by high-pressure liquid chromatography (HPLC). We also assayed pentobarbital content over time in preparations of various ages up to 6years old.
We determined that the drug degraded at a maximum of 0.5% per year in our preparation (alkaline water/propylene glycol/ethanol) when stored in the dark at room temperature. A yellow discoloration developed after about 2years, which we have arbitrarily determined disqualifies the preparation from use as an anesthetic. Attempts to spectroscopically assay this discoloration were not successful.
Pentobarbital sodium (CID: 14075609)</description><identifier>ISSN: 1056-8719</identifier><identifier>EISSN: 1873-488X</identifier><identifier>DOI: 10.1016/j.vascn.2015.07.012</identifier><identifier>PMID: 26234474</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adjuvants, Anesthesia - administration & dosage ; Adjuvants, Anesthesia - chemistry ; Adjuvants, Anesthesia - standards ; Animals ; Chemistry, Pharmaceutical ; Chromatography, High Pressure Liquid ; Drug Compounding - methods ; Drug Compounding - standards ; Drug Stability ; Drug Storage ; High-pressure liquid chromatography ; Injections ; Nembutal ; Pentobarbital ; Pentobarbital - administration & dosage ; Pentobarbital - chemistry ; Pentobarbital - standards ; Spectrophotometry, Ultraviolet ; Stability ; Time Factors</subject><ispartof>Journal of pharmacological and toxicological methods, 2015-11, Vol.76, p.38-42</ispartof><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-97a591022b984a103cd41804fa6aa19332dc0189c52b85581d18c8e51615c5f03</citedby><cites>FETCH-LOGICAL-c359t-97a591022b984a103cd41804fa6aa19332dc0189c52b85581d18c8e51615c5f03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1056871915000945$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26234474$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Priest, Sydney M.</creatorcontrib><creatorcontrib>Geisbuhler, Timothy P.</creatorcontrib><title>Injectable sodium pentobarbital: Stability at room temperature</title><title>Journal of pharmacological and toxicological methods</title><addtitle>J Pharmacol Toxicol Methods</addtitle><description>Sodium pentobarbital (Nembutal) is a barbiturate used in research as an anesthetic in many animal models. The injectable form of this drug has lately become difficult to procure and prohibitively expensive. Due to this lack of availability, researchers have begun to compound injectable sodium pentobarbital from so-called “nonpharmaceutical” pentobarbital. Some oversight agencies have objected to this practice, claiming a lack of quality control and degradation of the drug. We sought with this study to establish both: 1) a protocol for the preparation of injectable sodium pentobarbital, and 2) standard operating procedures to monitor the quality of the preparation and degradation of the drug over time.
Our preparation consists of a mixture of sodium pentobarbital in alkaline aqueous solution, propylene glycol, and ethanol. Pentobarbital content in this preparation was assayed by high-pressure liquid chromatography (HPLC). We also assayed pentobarbital content over time in preparations of various ages up to 6years old.
We determined that the drug degraded at a maximum of 0.5% per year in our preparation (alkaline water/propylene glycol/ethanol) when stored in the dark at room temperature. A yellow discoloration developed after about 2years, which we have arbitrarily determined disqualifies the preparation from use as an anesthetic. Attempts to spectroscopically assay this discoloration were not successful.
Pentobarbital sodium (CID: 14075609)</description><subject>Adjuvants, Anesthesia - administration & dosage</subject><subject>Adjuvants, Anesthesia - chemistry</subject><subject>Adjuvants, Anesthesia - standards</subject><subject>Animals</subject><subject>Chemistry, Pharmaceutical</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Drug Compounding - methods</subject><subject>Drug Compounding - standards</subject><subject>Drug Stability</subject><subject>Drug Storage</subject><subject>High-pressure liquid chromatography</subject><subject>Injections</subject><subject>Nembutal</subject><subject>Pentobarbital</subject><subject>Pentobarbital - administration & dosage</subject><subject>Pentobarbital - chemistry</subject><subject>Pentobarbital - standards</subject><subject>Spectrophotometry, Ultraviolet</subject><subject>Stability</subject><subject>Time Factors</subject><issn>1056-8719</issn><issn>1873-488X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMofv8CQXr00ppJmiYRFGTxCwQPKngLaToLWfqxJunC_nuru3r0NAPzvDPMQ8gZ0AIoVJeLYmWj6wtGQRRUFhTYDjkEJXleKvWxO_VUVLmSoA_IUYwLSinXUO6TA1YxXpayPCQ3T_0CXbJ1i1kcGj922RL7NNQ21D7Z9ip7nYa-9Wmd2ZSFYeiyhN0Sg01jwBOyN7dtxNNtPSbv93dvs8f8-eXhaXb7nDsudMq1tEIDZazWqrRAuWtKULSc28pa0JyzxlFQ2glWKyEUNKCcQgEVCCfmlB-Ti83eZRg-R4zJdD46bFvb4zBGA5IzoaWUMKF8g7owxBhwbpbBdzasDVDzLc4szI848y3OUGkmcVPqfHtgrDts_jK_pibgegPg9ObKYzDReewdNj5MAk0z-H8PfAGMqn7X</recordid><startdate>201511</startdate><enddate>201511</enddate><creator>Priest, Sydney M.</creator><creator>Geisbuhler, Timothy P.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201511</creationdate><title>Injectable sodium pentobarbital: Stability at room temperature</title><author>Priest, Sydney M. ; Geisbuhler, Timothy P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-97a591022b984a103cd41804fa6aa19332dc0189c52b85581d18c8e51615c5f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adjuvants, Anesthesia - administration & dosage</topic><topic>Adjuvants, Anesthesia - chemistry</topic><topic>Adjuvants, Anesthesia - standards</topic><topic>Animals</topic><topic>Chemistry, Pharmaceutical</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Drug Compounding - methods</topic><topic>Drug Compounding - standards</topic><topic>Drug Stability</topic><topic>Drug Storage</topic><topic>High-pressure liquid chromatography</topic><topic>Injections</topic><topic>Nembutal</topic><topic>Pentobarbital</topic><topic>Pentobarbital - administration & dosage</topic><topic>Pentobarbital - chemistry</topic><topic>Pentobarbital - standards</topic><topic>Spectrophotometry, Ultraviolet</topic><topic>Stability</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Priest, Sydney M.</creatorcontrib><creatorcontrib>Geisbuhler, Timothy P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmacological and toxicological methods</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Priest, Sydney M.</au><au>Geisbuhler, Timothy P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Injectable sodium pentobarbital: Stability at room temperature</atitle><jtitle>Journal of pharmacological and toxicological methods</jtitle><addtitle>J Pharmacol Toxicol Methods</addtitle><date>2015-11</date><risdate>2015</risdate><volume>76</volume><spage>38</spage><epage>42</epage><pages>38-42</pages><issn>1056-8719</issn><eissn>1873-488X</eissn><abstract>Sodium pentobarbital (Nembutal) is a barbiturate used in research as an anesthetic in many animal models. The injectable form of this drug has lately become difficult to procure and prohibitively expensive. Due to this lack of availability, researchers have begun to compound injectable sodium pentobarbital from so-called “nonpharmaceutical” pentobarbital. Some oversight agencies have objected to this practice, claiming a lack of quality control and degradation of the drug. We sought with this study to establish both: 1) a protocol for the preparation of injectable sodium pentobarbital, and 2) standard operating procedures to monitor the quality of the preparation and degradation of the drug over time.
Our preparation consists of a mixture of sodium pentobarbital in alkaline aqueous solution, propylene glycol, and ethanol. Pentobarbital content in this preparation was assayed by high-pressure liquid chromatography (HPLC). We also assayed pentobarbital content over time in preparations of various ages up to 6years old.
We determined that the drug degraded at a maximum of 0.5% per year in our preparation (alkaline water/propylene glycol/ethanol) when stored in the dark at room temperature. A yellow discoloration developed after about 2years, which we have arbitrarily determined disqualifies the preparation from use as an anesthetic. Attempts to spectroscopically assay this discoloration were not successful.
Pentobarbital sodium (CID: 14075609)</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26234474</pmid><doi>10.1016/j.vascn.2015.07.012</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1056-8719 |
ispartof | Journal of pharmacological and toxicological methods, 2015-11, Vol.76, p.38-42 |
issn | 1056-8719 1873-488X |
language | eng |
recordid | cdi_proquest_miscellaneous_1732597771 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adjuvants, Anesthesia - administration & dosage Adjuvants, Anesthesia - chemistry Adjuvants, Anesthesia - standards Animals Chemistry, Pharmaceutical Chromatography, High Pressure Liquid Drug Compounding - methods Drug Compounding - standards Drug Stability Drug Storage High-pressure liquid chromatography Injections Nembutal Pentobarbital Pentobarbital - administration & dosage Pentobarbital - chemistry Pentobarbital - standards Spectrophotometry, Ultraviolet Stability Time Factors |
title | Injectable sodium pentobarbital: Stability at room temperature |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T22%3A20%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Injectable%20sodium%20pentobarbital:%20Stability%20at%20room%20temperature&rft.jtitle=Journal%20of%20pharmacological%20and%20toxicological%20methods&rft.au=Priest,%20Sydney%20M.&rft.date=2015-11&rft.volume=76&rft.spage=38&rft.epage=42&rft.pages=38-42&rft.issn=1056-8719&rft.eissn=1873-488X&rft_id=info:doi/10.1016/j.vascn.2015.07.012&rft_dat=%3Cproquest_cross%3E1732597771%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1732597771&rft_id=info:pmid/26234474&rft_els_id=S1056871915000945&rfr_iscdi=true |